Drug
PF-05089771 clinical trials
Also written PF-05089771.
- studies test it
- 14
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
14 studies that test it; most in 2012 (4)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 10
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 1
Often tested with
Tested in the same studies.
PF-05105679 (1) · A 967079 (1) · PF-06305591 (1) · Pregabalin (1) · Pravastatin (1) · Midazolam (1) · Losartan (1) · Omeprazole (1)
Studies
Open first, then newest update. How each study uses PF-05089771 is read from its arms, and is right about nine times in ten.
Testing it · 14
- Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8CompletedEarly Phase 1Medical University of ViennaNCT05935280Written as PF-05089771
- Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) ErythromelalgiaCompletedPhase 2PfizerNCT01769274Written as PF-05089771
- Efficacy Of PF-05089771 In Treating Postoperative Dental PainCompletedPhase 2PfizerNCT01529346Written as PF-05089771
- A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)CompletedPhase 2PfizerNCT02215252Written as PF-05089771 150 mg
- Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain EndpointsCompletedPhase 1PfizerNCT02349607Written as PF-05089771 300mg
- Drug-Drug Interaction Study With PF-05089771CompletedPhase 1PfizerNCT01934569Written as Pravastatin, midazolam, losartan, omeprazole, caffeine and PF-05089771
- Relative Bioavailability With PF-05089771 Capsule Versus Oral DispersionCompletedPhase 1PfizerNCT01854996Written as PF-05089771
- Safety And Tolerability Study Of BID Titration Scheme With PF-05089771CompletedPhase 1PfizerNCT01772264Written as PF-05089771
- A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The KneeCompletedPhase 1PfizerNCT01529671Written as PF-05089771
- A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted StateCompletedPhase 1PfizerNCT01690351Written as PF-05089771
- A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed StateCompletedPhase 1PfizerNCT01563497Written as PF-05089771
- A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy VolunteersCompletedPhase 1PfizerNCT01259882Written as PF-05089771
- The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.CompletedPhase 1PfizerNCT01365637Written as PF-05089771
- To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological ActivityCompletedPhase 1PfizerNCT01165736Written as PF-05089771
Codes
What other systems call PF-05089771 · ClinicalTrials.gg INT000663
- Wikidata Q18359206PF-05089771One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q18359206 | PF-05089771 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.